Investigational New Drug Archives

X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)

Cryopreservation Technology Illustration

2 min read

X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)

X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, announces that...

First Patient Treated in Phase 2 GvHD Trial

Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, confirms that...

Investigational New Drug

X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)

First Patient Treated in Phase 2 GvHD Trial

Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for Novel MICA/B Antibody, CLN-619, for Relapsed/Refractory Multiple Myeloma

CDR-Life Announces FDA Clearance of IND Application for CDR404 for Treatment of Solid Tumors

Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study

Synthego Bridges Critical Preclinical Gap to Accelerate CRISPR-based Cell and Gene Therapies

You may have missed

TOP PMR SPECIALIST DR. AASTIK BHATT JOINS HCAH

1 IN 6 INDIVIDUALS STRUGGLE WITH INFERTILITY

Exactech Enhances High Technology Knee System with New Balancing Software

BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000